Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 80 articles:
HTML format



Single Articles


    March 2021
  1. BEHROOZIAN T, Milton L, Zhang L, Lou J, et al
    How do patient-reported outcomes compare with clinician assessments? A prospective study of radiation dermatitis in breast cancer.
    Radiother Oncol. 2021 Mar 23. pii: S0167-8140(21)06146.
    PubMed     Abstract available


  2. KIM N, Kim H, Hwang JH, Park W, et al
    Longitudinal impact of postmastectomy radiotherapy on arm lymphedema in patients with breast cancer: an analysis of serial changes in arm volume measured by infrared optoelectronic volumetry.
    Radiother Oncol. 2021 Mar 2. pii: S0167-8140(21)06096.
    PubMed     Abstract available


    February 2021
  3. MOUAWAD M, Lailey O, Poulsen P, O'Neil M, et al
    Intrafraction motion monitoring to determine PTV margins in early stage breast cancer patients receiving neoadjuvant partial breast SABR.
    Radiother Oncol. 2021 Feb 23. pii: S0167-8140(21)06084.
    PubMed     Abstract available


  4. VAN HULLE H, Desaunois E, Vakaet V, Paelinck L, et al
    Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: comparison with sequential boost in a randomized trial.
    Radiother Oncol. 2021 Feb 19. pii: S0167-8140(21)06070.
    PubMed     Abstract available


    January 2021
  5. LOUISE HOLM MILO M, Bech Jellesmark Thorsen L, Paaske Johnsen S, Melgaard Nielsen K, et al
    Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: A population-based Danish Breast Cancer Group study.
    Radiother Oncol. 2021 Jan 27. pii: S0167-8140(21)00010.
    PubMed     Abstract available


  6. DELANIAN S
    Is radiation-induced arteriopathy in long-term breast cancer survivors an underdiagnosed situation?: critical and pragmatic review of available literature.
    Radiother Oncol. 2021 Jan 27. pii: S0167-8140(21)00009.
    PubMed     Abstract available


    December 2020
  7. BOERSMA LJ, Murrer LHP
    Three large trials on radiotherapy for early breast cancer: what did we learn?
    Radiother Oncol. 2020 Dec 22. pii: S0167-8140(20)31244.
    PubMed    


    November 2020
  8. CJ BOSMA S, Hoogstraat M, van Werkhoven E, de Maaker M, et al
    A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients.
    Radiother Oncol. 2020 Nov 24. pii: S0167-8140(20)31195.
    PubMed    


  9. YANEY A, Ayan AS, Pan X, Jhawar S, et al
    Dosimetric Parameters Associated with Radiation-Induced Esophagitis in Breast Cancer Patients Undergoing Regional Nodal Irradiation.
    Radiother Oncol. 2020 Nov 3. pii: S0167-8140(20)30889.
    PubMed     Abstract available


  10. WIERCINSKA J, Winiecki J, Wronczewska A, Lebioda A, et al
    The use of hyaluronic acid hydrogel as a tumour bed marker in breast-conserving therapy.
    Radiother Oncol. 2020;152:8-13.
    PubMed     Abstract available


    October 2020
  11. RATOSA I, Chirila ME, Steinacher M, Kozma E, et al
    Hypofractionated radiation therapy for breast cancer: preferences amongst radiation oncologists in europe - results from an international survey.
    Radiother Oncol. 2020 Oct 13. pii: S0167-8140(20)30844.
    PubMed     Abstract available


  12. YAMAZAKI H, Suzuki G, Takenaka T, Aibe N, et al
    Objective and quantitative assessment in acute radiation-induced skin toxicity: Way to overcome the barriers?
    Radiother Oncol. 2020;151:304-305.
    PubMed    


    September 2020
  13. LOAP P, Tkatchenko N, Nicolas E, Fourquet A, et al
    Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapy.
    Radiother Oncol. 2020 Sep 29. pii: S0167-8140(20)30819.
    PubMed     Abstract available


  14. CHOI MS, Choi BS, Chung SY, Kim N, et al
    Clinical evaluation of atlas- and deep learning-based automatic segmentation of multiple organs and clinical target volumes for breast cancer.
    Radiother Oncol. 2020 Sep 26. pii: S0167-8140(20)30820.
    PubMed     Abstract available


  15. HYE CHOI K, Ja Ahn S, Uk Jeong J, Yu M, et al
    Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03.
    Radiother Oncol. 2020 Sep 24. pii: S0167-8140(20)30818.
    PubMed     Abstract available


  16. SONG J, Tang T, Caudrelier JM, Belec J, et al
    Dose-sparing effect of deep inspiration breath hold technique on coronary artery and left ventricle segments in treatment of breast cancer.
    Radiother Oncol. 2020 Sep 17. pii: S0167-8140(20)30792.
    PubMed     Abstract available


  17. JOSEPH K, Zebak S, Alba V, Mah K, et al
    Adjuvant breast radiotherapy, endocrine therapy after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study.
    Radiother Oncol. 2020 Sep 14. pii: S0167-8140(20)30789.
    PubMed     Abstract available


  18. HUANG H, Roberson J, Hou W, Mani K, et al
    NTCP model for hypothyroidism after supraclavicular-directed radiation therapy for breast cancer.
    Radiother Oncol. 2020 Sep 11. pii: S0167-8140(20)30772.
    PubMed     Abstract available


  19. FINNEGAN R, Lorenzen EL, Dowling J, Jensen I, et al
    Analysis of Cardiac Substructure Dose in a Large, Multi-Centre Danish Breast Cancer Cohort (the DBCG HYPO trial): Trends and Predictive Modelling.
    Radiother Oncol. 2020 Sep 8. pii: S0167-8140(20)30773.
    PubMed     Abstract available


    August 2020
  20. LAUGAARD LORENZEN E, Christian Rehammar J, Jensen MB, Ewertz M, et al
    Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977-2005.
    Radiother Oncol. 2020 Aug 25. pii: S0167-8140(20)30725.
    PubMed     Abstract available


    July 2020
  21. BATUMALAI V, Delaney GP, Descallar J, Gabriel G, et al
    Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications.
    Radiother Oncol. 2020 Jul 25. pii: S0167-8140(20)30686.
    PubMed     Abstract available


  22. JOURNY N, Schonfeld SJ, Hauptmann M, Roberti S, et al
    Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer.
    Radiother Oncol. 2020 Jul 14. pii: S0167-8140(20)30415.
    PubMed     Abstract available


    June 2020
  23. FERNANDO IN, Lax S, Ahmed I
    Response to Gultekin et al. regarding SECRAB trial toxicity.
    Radiother Oncol. 2020;147:233.
    PubMed    


    May 2020
  24. FASTNER G, Gaisberger C, Kaiser J, Scherer P, et al
    ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer.
    Radiother Oncol. 2020 May 12. pii: S0167-8140(20)30240.
    PubMed     Abstract available


    April 2020
  25. QUIRK S, Grendarova P, Phan T, Conroy L, et al
    A retrospective analysis to demonstrate achievable dosimetry for the left anterior descending artery in left-sided breast cancer patients treated with radiotherapy.
    Radiother Oncol. 2020;148:167-173.
    PubMed     Abstract available


    March 2020
  26. MULLIEZ T, Barbe K, de Ridder M
    Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy.
    Radiother Oncol. 2020 Mar 26. pii: S0167-8140(20)30153.
    PubMed     Abstract available


  27. FASTNER G, Reitsamer R, Urbanski B, Kopp P, et al
    Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
    Radiother Oncol. 2020;146:136-142.
    PubMed     Abstract available


  28. BOEKEL NB, Boekel LY, Buddeke J, Jacobse JN, et al
    Prognosis of acute coronary syndromes after radiotherapy for breast cancer.
    Radiother Oncol. 2020;146:110-117.
    PubMed     Abstract available


    February 2020
  29. GULTEKIN M, Tilki B, Yildiz F
    In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
    Radiother Oncol. 2020 Feb 18. pii: S0167-8140(20)30027.
    PubMed    


    January 2020
  30. PONS-TOSTIVINT E, Kirova Y, Lusque A, Campone M, et al
    Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis.
    Radiother Oncol. 2020;145:109-116.
    PubMed     Abstract available


  31. OLIVOTTO IA, Link E, Phillips C, Whelan TJ, et al
    International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
    Radiother Oncol. 2020;142:180-185.
    PubMed     Abstract available


    November 2019
  32. POULSEN PR, Thomsen MS, Hansen R, Worm E, et al
    Fully automated detection of heart irradiation in cine MV images acquired during breast cancer radiotherapy.
    Radiother Oncol. 2019 Nov 28. pii: S0167-8140(19)33472.
    PubMed     Abstract available


  33. FERNANDO IN, Bowden SJ, Herring K, Brookes CL, et al
    Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
    Radiother Oncol. 2019 Nov 27. pii: S0167-8140(19)33450.
    PubMed     Abstract available


  34. JANG BS, Han W, Kim IA
    Tumor mutation burden, immune checkpoint crosstalk and radiosensitivity in single-cell RNA sequencing data of breast cancer.
    Radiother Oncol. 2019 Nov 22. pii: S0167-8140(19)33469.
    PubMed     Abstract available


    October 2019
  35. ALMAHARIQ MF, Quinn TJ, Siddiqui Z, Jawad MS, et al
    Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
    Radiother Oncol. 2019 Oct 12. pii: S0167-8140(19)33107.
    PubMed     Abstract available


    September 2019
  36. BORM KJ, Oechsner M, Dusberg M, Buschner G, et al
    Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design.
    Radiother Oncol. 2019 Sep 17. pii: S0167-8140(19)33067.
    PubMed     Abstract available


    August 2019
  37. MUTTER RW
    ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer.
    Radiother Oncol. 2019 Aug 23. pii: S0167-8140(19)33012.
    PubMed    


  38. KAIDAR-PERSON O, Offersen BV, Poortmans P
    Should risk-adapted delineation considered de-escalation of therapy? The ESTRO-ACROP radiation therapy guidelines after implant-based immediate reconstruction for early stage breast cancer.
    Radiother Oncol. 2019 Aug 23. pii: S0167-8140(19)33025.
    PubMed    


    May 2019
  39. KAIDAR-PERSON O, Vrou Offersen B, Hol S, Arenas M, et al
    ESTRO consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer.
    Radiother Oncol. 2019;137:159-166.
    PubMed     Abstract available


    April 2019
  40. STICK LB, Vogelius IR, Modiri A, Rice SR, et al
    Inverse radiotherapy planning based on bioeffect modelling for locally advanced left-sided breast cancer.
    Radiother Oncol. 2019;136:9-14.
    PubMed     Abstract available


  41. VAN DEN BOGAARD VAB, van Dijk LV, Vliegenthart R, Sijtsema NM, et al
    Development and evaluation of an auto-segmentation tool for the left anterior descending coronary artery of breast cancer patients based on anatomical landmarks.
    Radiother Oncol. 2019;136:15-20.
    PubMed     Abstract available


    March 2019
  42. KALLIS K, Kaltsas T, Kreppner S, Lotter M, et al
    Impact of inter- and intra-observer variabilities of catheter reconstruction on multi-catheter interstitial brachytherapy of breast cancer patients.
    Radiother Oncol. 2019;135:25-32.
    PubMed     Abstract available


  43. HAQUE W, Verma V, Farach A, Brian Butler E, et al
    Postmastectomy radiation therapy for triple negative, node-negative breast cancer.
    Radiother Oncol. 2019;132:48-54.
    PubMed     Abstract available


    February 2019
  44. MOUAWAD M, Biernaski H, Brackstone M, Lock M, et al
    Reducing the dose of gadolinium-based contrast agents for DCE-MRI guided SBRT: The effects on inter and intra observer variability for preoperative target volume delineation in early stage breast cancer patients.
    Radiother Oncol. 2019;131:60-65.
    PubMed     Abstract available


  45. MILANO MT, Katz AW, Zhang H, Huggins CF, et al
    Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade.
    Radiother Oncol. 2019;131:45-51.
    PubMed     Abstract available


  46. KAWAMOTO T, Shikama N, Sasai K
    Severe acute radiation-induced enterocolitis after combined palbociclib and palliative radiotherapy treatment.
    Radiother Oncol. 2019;131:240-241.
    PubMed    


    November 2018
  47. WANG W, Ward R, Jia D, Ashworth S, et al
    Location of arm draining lymph node in relation to breast cancer radiotherapy field and target volume.
    Radiother Oncol. 2018 Nov 13. pii: S0167-8140(18)33579.
    PubMed     Abstract available


  48. TANG S, Otton J, Holloway L, Delaney GP, et al
    Quantification of cardiac subvolume dosimetry using a 17 segment model of the left ventricle in breast cancer patients receiving tangential beam radiotherapy.
    Radiother Oncol. 2018 Nov 13. pii: S0167-8140(18)33505.
    PubMed     Abstract available


  49. LUO L, Cuaron J, Braunstein L, Gillespie E, et al
    Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy.
    Radiother Oncol. 2018 Nov 7. pii: S0167-8140(18)33507.
    PubMed     Abstract available


  50. TRIVEDI SJ, Choudhary P, Lo Q, Sritharan HP, et al
    Persistent reduction in global longitudinal strain in the longer term after radiation therapy in patients with breast cancer.
    Radiother Oncol. 2018 Nov 7. pii: S0167-8140(18)33547.
    PubMed     Abstract available


    September 2018
  51. KUNDRAT P, Remmele J, Rennau H, Sebb S, et al
    Minimum breast distance largely explains individual variability in doses to contralateral breast from breast-cancer radiotherapy.
    Radiother Oncol. 2018 Sep 18. pii: S0167-8140(18)33462.
    PubMed     Abstract available


  52. KARAGIANNIS E, Leczynski A, Tselis N, Psanis E, et al
    Inverse planning and inverse implanting for breast interstitial brachytherapy. Introducing a new anatomy specific breast interstitial template (ASBIT).
    Radiother Oncol. 2018;128:421-427.
    PubMed     Abstract available


  53. HOEKSTRA N, Fleury E, Merino Lara TR, van der Baan P, et al
    Long-term risks of secondary cancer for various whole and partial breast irradiation techniques.
    Radiother Oncol. 2018;128:428-433.
    PubMed     Abstract available


    August 2018
  54. LISSIDINI G, Trifiro G, Veronesi P, Grana C, et al
    Could radiotherapy play a major role in misidentification of sentinel lymph node in breast cancer recurrence?
    Radiother Oncol. 2018 Aug 30. pii: S0167-8140(18)33439.
    PubMed     Abstract available


  55. KADERKA R, Gillespie EF, Mundt RC, Bryant AK, et al
    Geometric and dosimetric evaluation of atlas based auto-segmentation of cardiac structures in breast cancer patients.
    Radiother Oncol. 2018 Aug 11. pii: S0167-8140(18)33405.
    PubMed     Abstract available


  56. SIMONETTO C, Eidemuller M, Gaasch A, Pazos M, et al
    Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy.
    Radiother Oncol. 2018 Aug 7. pii: S0167-8140(18)33423.
    PubMed     Abstract available


    July 2018
  57. GREGOROWITSCH ML, Verkooijen HM, Houweling A, Fuhler N, et al
    Impact of modern-day axillary treatment on patient reported arm morbidity and physical functioning in breast cancer patients.
    Radiother Oncol. 2018 Jul 19. pii: S0167-8140(18)33385.
    PubMed     Abstract available


  58. BROUWERS PJAM, van Werkhoven E, Bartelink H, Fourquet A, et al
    Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.
    Radiother Oncol. 2018 Jul 3. pii: S0167-8140(18)33335.
    PubMed     Abstract available


    May 2018
  59. MANCOSU P, Nicolini G, Goretti G, De Rose F, et al
    Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case.
    Radiother Oncol. 2018;127:326-331.
    PubMed     Abstract available


    April 2018
  60. GERNAAT SAM, van Velzen SGM, Koh V, Emaus MJ, et al
    Automatic quantification of calcifications in the coronary arteries and thoracic aorta on radiotherapy planning CT scans of Western and Asian breast cancer patients.
    Radiother Oncol. 2018 Apr 24. pii: S0167-8140(18)30199.
    PubMed     Abstract available


  61. STRNAD V, Major T, Polgar C, Lotter M, et al
    ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
    Radiother Oncol. 2018 Apr 21. pii: S0167-8140(18)30197.
    PubMed     Abstract available


    March 2018
  62. KAHAN Z, Rarosi F, Gaal S, Cserhati A, et al
    A simple clinical method for predicting the benefit of prone vs. supine positioning in reducing heart exposure during left breast radiotherapy.
    Radiother Oncol. 2018;126:487-492.
    PubMed     Abstract available


    February 2018
  63. MUNSHI A
    The arrival of axilla conserving therapy (ACT). Is this the second revolution in locoregional management of breast cancer care?
    Radiother Oncol. 2018 Feb 23. pii: S0167-8140(18)30066.
    PubMed    


    January 2018
  64. MONTEN C, Lievens Y
    Adjuvant breast radiotherapy: How to trade-off cost and effectiveness?
    Radiother Oncol. 2018;126:132-138.
    PubMed     Abstract available


  65. HAVILAND JS, Mannino M, Griffin C, Porta N, et al
    Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials.
    Radiother Oncol. 2018;126:155-162.
    PubMed     Abstract available


    December 2017
  66. AZNAR MC, Duane FK, Darby SC, Wang Z, et al
    Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015.
    Radiother Oncol. 2017 Dec 12. pii: S0167-8140(17)32742.
    PubMed     Abstract available


    October 2017
  67. ROOS CTG, van den Bogaard VAB, Greuter MJW, Vliegenthart R, et al
    Is the coronary artery calcium score associated with acute coronary events in breast cancer patients treated with radiotherapy?
    Radiother Oncol. 2017 Oct 28. pii: S0167-8140(17)32649.
    PubMed     Abstract available


  68. CHANG JS, Lee J, Chun M, Shin KH, et al
    Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume.
    Radiother Oncol. 2017 Oct 16. pii: S0167-8140(17)32617.
    PubMed     Abstract available


    September 2017
  69. HANS S, Cottu P, Kirova YM
    Preliminary results of the association of Palbociclib and radiotherapy in metastatic breast cancer patients.
    Radiother Oncol. 2017 Sep 27. pii: S0167-8140(17)32577.
    PubMed    


  70. TROVO M, Furlan C, Polesel J, Fiorica F, et al
    Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
    Radiother Oncol. 2017 Sep 21. pii: S0167-8140(17)32556.
    PubMed     Abstract available


  71. QI XS, Pajonk F, McCloskey S, Low DA, et al
    Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation.
    Radiother Oncol. 2017;124:455-461.
    PubMed     Abstract available


  72. COLLIS J, Hill MR, Nicol JR, Paine PJ, et al
    A hierarchical Bayesian approach to calibrating the linear-quadratic model from clonogenic survival assay data.
    Radiother Oncol. 2017;124:541-546.
    PubMed     Abstract available


  73. JANG BS, Kim IA
    A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
    Radiother Oncol. 2017;124:403-410.
    PubMed     Abstract available


    August 2017
  74. ARISTEI C, Maranzano E, Lancellotta V, Chirico L, et al
    Partial breast irradiation with interstitial multi-catheter high-dose-rate brachytherapy. Long-term results of a phase II prospective study.
    Radiother Oncol. 2017;124:208-213.
    PubMed     Abstract available


  75. MIGNOT F, Ajgal Z, Xu H, Geraud A, et al
    Concurrent administration of anti-HER2 therapy and radiotherapy: Systematic review.
    Radiother Oncol. 2017;124:190-199.
    PubMed     Abstract available


  76. BRONSART E, Dureau S, Xu HP, Bazire L, et al
    Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results.
    Radiother Oncol. 2017;124:214-219.
    PubMed     Abstract available


  77. BAUMANN BC, Zeng C, Freedman GM, Verginadis II, et al
    Avoiding antiperspirants during breast radiation therapy: Myth or sound advice?
    Radiother Oncol. 2017;124:204-207.
    PubMed     Abstract available


  78. DEMOOR-GOLDSCHMIDT C, Supiot S, Oberlin O, Helfre S, et al
    Clinical and diagnosis characteristics of breast cancers in women with a history of radiotherapy in the first 30years of life: A French multicentre cohort study.
    Radiother Oncol. 2017;124:200-203.
    PubMed     Abstract available


    July 2017
  79. MIGUEZ C, Jimenez-Ortega E, Palma BA, Miras H, et al
    Clinical implementation of combined modulated electron and photon beams with conventional MLC for accelerated partial breast irradiation.
    Radiother Oncol. 2017;124:124-129.
    PubMed     Abstract available


    May 2017
  80. KLEMENT RJ, Guckenberger M, Alheid H, Allgauer M, et al
    Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control.
    Radiother Oncol. 2017;123:227-233.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: